Evaluation of Antidiarrheal, Antispasmodic, and Antisecretory Activities of Extract and Fractions of Castanopsis costata Leaves in Animal Models

Alkandahri, Maulana Yusuf; Sholih, Mally Ghinan; Fadilah, Nitya Nurul; Arfania, Maya; Amal, Surya; Frianto, Dedy; Mardiana, Lina Aliyani; Astuti, Diany; Hasyim, Dadang Muhammad

doi:10.5530/pj.2023.15.5

Cited by 1 publication

(1 citation statement)

References 29 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Leaf extract of this plant has been used empirically for the treatment of fever, digestive disorders, inflammation, wound healing, and pain relief ( 9 ). Meanwhile, several previous studies reported that C. costata leaf extract has pharmacological activity such as antimalarial ( 10 ), antidiabetic ( 11 ), anti-hypercholesterolemia ( 12 ), antioxidant ( 7 ), and antidiarrheal ( 13 ). Although there is an existing report on the traditional and scientific use of C. costata leaf extract, there are no reports in the literature on the anti-inflammatory, antipyretic, analgesic, and antioxidant activities of C. costata leaf fractions (CcLF).…”

Section: Introductionmentioning

confidence: 99%

Pharmacological evaluation of anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (water, ethyl acetate, and n-hexane fractions): the potential medicinal plants from North Sumatra, Indonesia

Alkandahri,

Sadino,

Pamungkas

et al. 2024

Research in Pharmaceutical Sciences

Self Cite

View full text Add to dashboard Cite

Background and purpose: Inflammation, fever, and pain can be associated with several diseases, and the synthetic drugs used in the treatment of these conditions often have severe side effects. As a result, there is a need for effective, economical, and safe alternative drugs, such as those derived from medicinal plants. Therefore, this study aimed to evaluate the anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (CcLF), as well as its acute toxicity. Experimental approach: For anti-inflammatory, antipyretic, and analgesic tests, rats were given CcLF (WFCC, EAFcC, and n-HFCC) at 50 and 100 mg/kg, diclofenac sodium (10 mg/kg), paracetamol (150 mg/kg), aspirin (100 mg/kg), and tramadol (20 mg/kg). For the antioxidant activity test, various concentrations of CcLF were used ranging from 25 to 200 μg/mL. This study also looked into whether there could be any acute toxicity and histopathology of the liver, stomach, and kidneys in experimental animals. Findings/Results: The administration of CcLF significantly inhibited the increase in foot edema volume, and CcLF (EAFCC at 100 mg/kg) considerably decreased rectal temperature and was proportional to the standard drug paracetamol, and significantly inhibited pain sensation in various models. Additionally, CcLF showed strong antioxidant activity, and its administration at a dose limit of 5000 mg/kg/day did not show any toxic effects or death in test animals. Conclusions and implications: The results of the current confirmed that CcLF has demonstrated anti-inflammatory, antipyretic, analgesic, and antioxidant properties in experimental models, and is practically non-toxic.

show abstract